12 Aug, 2026 4:01 PM (IST)
Novelix Pharmaceuticals Performance
- Today's Low
- ₹73
- Today's High
- ₹79
- 52 Week Low
- ₹38
- 52 Week High
- ₹92
- Open Price₹79
- Previous Close₹77
- Volume2,342
- 50 DMA₹69.80
- 100 DMA₹66.10
- 200 DMA₹59.30
Novelix Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 9.71%
- Over 3 Month + 32.99%
- Over 6 Month + 16.59%
- Over 1 Year + 82.86%
Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!
Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 50.3
- PEG Ratio
- 0
- Market Cap Cr
- 129
- P/B Ratio
- 3
- Average True Range
- 4.6
- EPS
- 1.5
- Dividend Yield
- 0
- MACD Signal
- 0.7
- RSI
- 52.82
- MFI
- 57.49
Latest Stock News Updates
Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Submission of prior Intimation of Board meeting.
- BSE India
- 3 days 3 hours ago
Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
- BSE India
- 3 weeks 6 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vupparapalli Chandrasekhar Reddy & Others
- BSE India
- 4 weeks 2 days ago
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 3
- Bullish Moving Average 13
- 20 Day
- ₹71.50
- 50 Day
- ₹69.80
- 100 Day
- ₹66.10
- 200 Day
- ₹59.30
Resistance and Support
- R3 83.00
- R2 81.00
- R1 77.00
- S1 71.00
- S2 69.00
- S3 65.00
Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-13 | Quarterly Results | |
| 2026-06-04 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Approve the Draft Notice of EGM. 2.Fix the day, date, time & venue of EGM. 3. Appoint Scrutinizer for conducting E- voting process for EGM. 4. Other business matters. |
| 2026-05-29 | Audited Results & Preferential issue | |
| 2026-02-12 | Quarterly Results | |
| 2025-11-13 | Quarterly Results |
About Novelix Pharmaceuticals
Novelix Pharmaceuticals is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities. View More- NSE Symbol
- NOVELIX
- BSE Symbol
- 536565
- ISIN
- INE314I01036
Similar Stocks to Novelix Pharmaceuticals
Popular Stocks
Novelix Pharmaceuticals FAQs
Novelix Pharmaceuticals share price is ₹72 As on 12 August, 2026 | 22:19
The Market Cap of Novelix Pharmaceuticals is ₹128.5 Cr As on 12 August, 2026 | 22:19
The P/E ratio of Novelix Pharmaceuticals is 50.3 As on 12 August, 2026 | 22:19
The PB ratio of Novelix Pharmaceuticals is 3 As on 12 August, 2026 | 22:19
The 52 week High & Low of Novelix Pharmaceuticals is ₹92/₹38 respectively As on 12 August, 2026 | 22:19
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.